MBRX - Moleculin Biotech EPS misses by $0.08 August, 12 2020 07:38 AM Moleculin Biotech Inc. Moleculin Biotech (NASDAQ:MBRX): Q2 GAAP EPS of -$0.17 misses by $0.08.Cash and cash equivalents of $16.7M.Press ReleaseMore news on: Moleculin Biotech, Inc., Earnings news and commentary, Healthcare stocks news, ,